Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|March 21, 2021
Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agentsSaif Ullah, Mohammed I El-Gamal, Randa El-Gamal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 5, 2014
Vitiligo: characterization of melanocytes in repigmented skin after punch graftingD Kovacs, H Abdel-Raouf, M Al-Khayyat, et al.
International Journal of Dermatology|May 26, 2018
Syringes versus Chinese cups in harvesting suction-induced blister graft: a randomized split-body studyTag S Anbar, Nayera H Moftah, Mohammad A M El-Khayyat, et al.
Bioorganic & Medicinal Chemistry|May 16, 2019
Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitorsMohammad H Semreen, Mohammed I El-Gamal, Saif Ullah, et al.
European Journal of Medicinal Chemistry|January 11, 2020
Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigationsAbduelmula R Abduelkarem, Hanan S Anbar, Seyed-Omar Zaraei, et al.
Bioorganic & Medicinal Chemistry|March 17, 2020
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluationMohammed I El-Gamal, Seyed-Omar Zaraei, Paul A Foster, et al.
BMC Cancer|November 3, 2023
Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinasesRanda El-Gamal, Sara Elfarrash, Mohammad El-Nablaway, et al.
Expert Opinion on Therapeutic Patents|March 30, 2021
Steroid sulfatase inhibitors: the current landscapeHanan S Anbar, Zahraa Isa, Jana J Elounais, et al.
Archiv Der Pharmazie|June 29, 2024
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024)Esra M Mustafa, Afnan I Shahin, Aishah S Alrashed, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2022
Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activityHanan S Anbar, Naglaa G Shehab, Nadia M M El-Rouby, et al.
Pageof 7